Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000513273 | SCV000609114 | uncertain significance | not provided | 2017-03-01 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000666996 | SCV000791381 | uncertain significance | Glycogen storage disease, type IV | 2017-05-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001080686 | SCV001115023 | likely benign | Glycogen storage disease, type IV; Glycogen storage disease IV, classic hepatic | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001149393 | SCV001310342 | benign | Adult polyglucosan body disease | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV000666996 | SCV001310343 | benign | Glycogen storage disease, type IV | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Centre for Mendelian Genomics, |
RCV000666996 | SCV001368278 | benign | Glycogen storage disease, type IV | 2018-10-29 | criteria provided, single submitter | clinical testing | This variant was classified as: Benign. The following ACMG criteria were applied in classifying this variant: BS1,BS2. |
Gene |
RCV000513273 | SCV001947863 | benign | not provided | 2019-04-18 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27790088, 25133958, 31692161) |
Natera, |
RCV000666996 | SCV001460905 | benign | Glycogen storage disease, type IV | 2020-01-13 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004535652 | SCV004728727 | likely benign | GBE1-related disorder | 2019-05-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |